The DOI matches its Crossref record; 270 of the 270 references it cites were found in a registry or an index.
Neuromyelitis optica: clinical features, immunopathogenesis and treatment
Open accessAbstract
Summary: The term ‘neuromyelitis optica’ (‘Devic's syndrome’, NMO) refers to a syndrome characterized by optic neuritis and myelitis. In recent years, the condition has raised enormous interest among scientists and clinical neurologists, fuelled by the detection of a specific serum immunoglobulin (Ig)G reactivity (NMO-IgG) in up to 80% of patients with NMO. These autoantibodies were later shown to target aquaporin-4 (AQP4), the most abundant water channel in the central nervous system (CNS). Here we give an up-to-date overview of the clinical and paraclinical features, immunopathogenesis and treatment of NMO. We discuss the widening clinical spectrum of AQP4-related autoimmunity, the role of magnetic resonance imaging (MRI) and new diagnostic means such as optical coherence tomography in the diagnosis of NMO, the role of NMO-IgG, T cells and granulocytes in the pathophysiology of NMO, and outline prospects for new and emerging therapies for this rare, but often devastating condition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
Lennon, V. A., Wingerchuk, D. M., Kryzer, T. J., Pittock, S. J., Lucchinetti, C. F., Fujihara, K., Nakashima, I., & Weinshenker, B. G. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17551-x · Cited by 3,239
Revised diagnostic criteria for neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Pittock, S. J., Lucchinetti, C. F., & Weinshenker, B. G. (2006) · Neurology · doi:10.1212/01.wnl.0000216139.44259.74 · Cited by 2,574
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
Lennon, V. A., Kryzer, T. J., Pittock, S. J., Verkman, A. S., & Hinson, S. R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050304 · Cited by 2,288
The spectrum of neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Lucchinetti, C. F., Pittock, S. J., & Weinshenker, B. G. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70216-8 · Cited by 2,179
The clinical course of neuromyelitis optica (Devic’s syndrome)
Wingerchuk, D. M., Hogancamp, W. F., O’Brien, P. C., & Weinshenker, B. G. (1999) · Neurology · doi:10.1212/wnl.53.5.1107 · Cited by 1,822
A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica
Lucchinetti, C. F. (2002) · Brain · doi:10.1093/brain/awf151 · Cited by 1,210
Krupp, L. B., Tardieu, M., Amato, M. P., Banwell, B., Chitnis, T., Dale, R. C., Ghezzi, A., Hintzen, R., Kornberg, A., Pohl, D., et al. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513484547 · Cited by 1,130
Jarius, S., Ruprecht, K., Wildemann, B., Kuempfel, T., Ringelstein, M., Geis, C., Kleiter, I., Kleinschnitz, C., Berthele, A., Brettschneider, J., et al. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-14 · Cited by 764
Self-citationCerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.
Andersson, M., Alvarez-Cermeno, J., Bernardi, G., Cogato, I., Fredman, P., Frederiksen, J., Fredrikson, S., Gallo, P., Grimaldi, L. M., Gronning, M., et al. (1994) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.8.897 · Cited by 741
Roemer, S. F., Parisi, J. E., Lennon, V. A., Benarroch, E. E., Lassmann, H., Bruck, W., Mandler, R. N., Weinshenker, B. G., Pittock, S. J., Wingerchuk, D. M., et al. (2007) · Brain · doi:10.1093/brain/awl371 · Cited by 716
Neuromyelitis Optica Brain Lesions Localized at Sites of High Aquaporin 4 Expression
Pittock, S. J., Weinshenker, B. G., Lucchinetti, C. F., Wingerchuk, D. M., Corboy, J. R., & Lennon, V. A. (2006) · Archives of Neurology · doi:10.1001/archneur.63.7.964 · Cited by 701
Brain Abnormalities in Neuromyelitis Optica
Pittock, S. J., Lennon, V. A., Krecke, K., Wingerchuk, D. M., Lucchinetti, C. F., & Weinshenker, B. G. (2006) · Archives of Neurology · doi:10.1001/archneur.63.3.390 · Cited by 675
An open label study of the effects of rituximab in neuromyelitis optica
Cree, B. A. C., Lamb, S., Morgan, K., Chen, A., Waubant, E., & Genain, C. (2005) · Neurology · doi:10.1212/01.wnl.0000159399.81861.d5 · Cited by 646
Paty, D. W., Oger, J. J. F., Kastrukoff, L. F., Hashimoto, S. A., Hooge, J. P., Eisen, A. A., Eisen, K. A., Purves, S. J., Low, M. D., Brandejs, V., et al. (1988) · Neurology · doi:10.1212/wnl.38.2.180 · Cited by 639
Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre
Takahashi, T., Fujihara, K., Nakashima, I., Misu, T., Miyazawa, I., Nakamura, M., Watanabe, S., Shiga, Y., Kanaoka, C., Fujimori, J., et al. (2007) · Brain · doi:10.1093/brain/awm062 · Cited by 633
Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis
Misu, T., Fujihara, K., Kakita, A., Konno, H., Nakamura, M., Watanabe, S., Takahashi, T., Nakashima, I., Takahashi, H., & Itoyama, Y. (2007) · Brain · doi:10.1093/brain/awm047 · Cited by 614
Neuromyelitis Optica and Non–Organ-Specific Autoimmunity
Pittock, S. J., Lennon, V. A., de Seze, J., Vermersch, P., Homburger, H. A., Wingerchuk, D. M., Lucchinetti, C. F., Zéphir, H., Moder, K., & Weinshenker, B. G. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.17 · Cited by 608
Aquaporin 4 and neuromyelitis optica
Papadopoulos, M. C., & Verkman, A. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70133-3 · Cited by 597
Neuromyelitis Optica Study Group (NEMOS), Trebst, C., Jarius, S., Berthele, A., Paul, F., Schippling, S., Wildemann, B., Borisow, N., Kleiter, I., Aktas, O., et al. (2014) · Journal of Neurology · doi:10.1007/s00415-013-7169-7 · Cited by 595
Self-citationIntrathecal pathogenic anti–aquaporin‐4 antibodies in early neuromyelitis optica
Bennett, J. L., Lam, C., Kalluri, S. R., Saikali, P., Bautista, K., Dupree, C., Glogowska, M., Case, D., Antel, J. P., Owens, G. P., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21802 · Cited by 590
Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis
Weinshenker, B. G., Wingerchuk, D. M., Vukusic, S., Linbo, L., Pittock, S. J., Lucchinetti, C. F., & Lennon, V. A. (2006) · Annals of Neurology · doi:10.1002/ana.20770 · Cited by 588
Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo
Bradl, M., Misu, T., Takahashi, T., Watanabe, M., Mader, S., Reindl, M., Adzemovic, M., Bauer, J., Berger, T., Fujihara, K., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21837 · Cited by 563
Saadoun, S., Waters, P., Bell, B. A., Vincent, A., Verkman, A. S., & Papadopoulos, M. C. (2010) · Brain · doi:10.1093/brain/awp309 · Cited by 548
Proinflammatory T helper type 17 cells are effective B-cell helpers
Mitsdoerffer, M., Lee, Y., Jäger, A., Kim, H.-J., Korn, T., Kolls, J. K., Cantor, H., Bettelli, E., & Kuchroo, V. K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009234107 · Cited by 534
Serologic diagnosis of NMO: A multicenter comparison of aquaporin-4-IgG assays
Waters, P. J., McKeon, A., Leite, M. I., Rajasekharan, S., Lennon, V. A., Villalobos, A., Palace, J., Mandrekar, J. N., Vincent, A., Bar-Or, A., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318248dec1 · Cited by 526
Korn, T., Mitsdoerffer, M., Croxford, A. L., Awasthi, A., Dardalhon, V. A., Galileos, G., Vollmar, P., Stritesky, G. L., Kaplan, M. H., Waisman, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809850105 · Cited by 508
Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica
Hinson, S. R., Pittock, S. J., Lucchinetti, C. F., Roemer, S. F., Fryer, J. P., Kryzer, T. J., & Lennon, V. A. (2007) · Neurology · doi:10.1212/01.wnl.0000289761.64862.ce · Cited by 494
Chihara, N., Aranami, T., Sato, W., Miyazaki, Y., Miyake, S., Okamoto, T., Ogawa, M., Toda, T., & Yamamura, T. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017385108 · Cited by 474
Treatment of Neuromyelitis Optica With Rituximab: Retrospective Analysis of 25 Patients
(2008) · Archives of Neurology · doi:10.1001/archneur.65.11.noc80069 · Cited by 459
Mader, S., Gredler, V., Schanda, K., Rostasy, K., Dujmovic, I., Pfaller, K., Lutterotti, A., Jarius, S., Di Pauli, F., Kuenz, B., et al. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-184 · Cited by 449
Self-citationMyelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype
Kitley, J., Woodhall, M., Waters, P., Leite, M. I., Devenney, E., Craig, J., Palace, J., & Vincent, A. (2012) · Neurology · doi:10.1212/wnl.0b013e31826aac4e · Cited by 445
Kitley, J., Leite, M. I., Nakashima, I., Waters, P., McNeillis, B., Brown, R., Takai, Y., Takahashi, T., Misu, T., Elsone, L., et al. (2012) · Brain · doi:10.1093/brain/aws109 · Cited by 438
Antibody to aquaporin-4 in the long-term course of neuromyelitis optica
Jarius, S., Aboul-Enein, F., Waters, P., Kuenz, B., Hauser, A., Berger, T., Lang, W., Reindl, M., Vincent, A., & Kristoferitsch, W. (2008) · Brain · doi:10.1093/brain/awn240 · Cited by 435
Self-citationAQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance
Jarius, S., & Wildemann, B. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.72 · Cited by 423
Self-citationPittock, S. J., Lennon, V. A., McKeon, A., Mandrekar, J., Weinshenker, B. G., Lucchinetti, C. F., O'Toole, O., & Wingerchuk, D. M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70076-0 · Cited by 395
NMO-IgG predicts the outcome of recurrent optic neuritis
Matiello, M., Lennon, V. A., Jacob, A., Pittock, S. J., Lucchinetti, C. F., Wingerchuk, D. M., & Weinshenker, B. G. (2008) · Neurology · doi:10.1212/01.wnl.0000303817.82134.da · Cited by 367
Mandler, R. N., Ahmed, W., & Dencoff, J. E. (1998) · Neurology · doi:10.1212/wnl.51.4.1219 · Cited by 366
Jarius, S., Paul, F., Franciotta, D., Ruprecht, K., Ringelstein, M., Bergamaschi, R., Rommer, P., Kleiter, I., Stich, O., Reuss, R., et al. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.03.038 · Cited by 361
Self-citationHinson, S. R., Roemer, S. F., Lucchinetti, C. F., Fryer, J. P., Kryzer, T. J., Chamberlain, J. L., Howe, C. L., Pittock, S. J., & Lennon, V. A. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081241 · Cited by 355
Varrin‐Doyer, M., Spencer, C. M., Schulze‐Topphoff, U., Nelson, P. A., Stroud, R. M., C. Cree, B. A., & Zamvil, S. S. (2012) · Annals of Neurology · doi:10.1002/ana.23651 · Cited by 341
Mechanisms of Disease: aquaporin-4 antibodies in neuromyelitis optica
Jarius, S., Paul, F., Franciotta, D., Waters, P., Zipp, F., Hohlfeld, R., Vincent, A., & Wildemann, B. (2008) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0764 · Cited by 335
Self-citationIntrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis
Ishizu, T., Osoegawa, M., Mei, F.-J., Kikuchi, H., Tanaka, M., Takakura, Y., Minohara, M., Murai, H., Mihara, F., Taniwaki, T., et al. (2005) · Brain · doi:10.1093/brain/awh453 · Cited by 334
IL-6 Signaling in Psoriasis Prevents Immune Suppression by Regulatory T Cells
Goodman, W. A., Levine, A. D., Massari, J. V., Sugiyama, H., McCormick, T. S., & Cooper, K. D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803721 · Cited by 329
Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes
Hinson, S. R., Romero, M. F., Popescu, B. F. G., Lucchinetti, C. F., Fryer, J. P., Wolburg, H., Fallier-Becker, P., Noell, S., & Lennon, V. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109980108 · Cited by 328
A secondary progressive clinical course is uncommon in neuromyelitis optica
Wingerchuk, D. M., Pittock, S. J., Lucchinetti, C. F., Lennon, V. A., & Weinshenker, B. G. (2007) · Neurology · doi:10.1212/01.wnl.0000254502.87233.9a · Cited by 326
Palace, J., Leite, M. I., Nairne, A., & Vincent, A. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.188 · Cited by 322
The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis
Reiber, H., Ungefehr, S., & Jacobi, C. (1998) · Multiple Sclerosis Journal · doi:10.1177/135245859800400304 · Cited by 317
Treatment of Neuromyelitis Optica With Mycophenolate Mofetil: Retrospective Analysis of 24 Patients
Jacob, A., Matiello, M., Weinshenker, B. G., Wingerchuk, D. M., Lucchinetti, C., Shuster, E., Carter, J., Keegan, B. M., Kantarci, O. H., & Pittock, S. J. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.175 · Cited by 308
Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies
Ratchford, J. N., Quigg, M., Conger, A., Frohman, T. C., Frohman, E. M., Balcer, L. J., Calabresi, P. A., & Kerr, D. A. (2009) · Neurology · doi:10.1212/wnl.0b013e3181af78b8 · Cited by 303
Neuromyelitis optica unique area postrema lesions: Nausea, vomiting, and pathogenic implications
Popescu, B. F. G., Lennon, V. A., Parisi, J. E., Howe, C. L., Weigand, S. D., Cabrera-Gómez, J. A., Newell, K., Mandler, R. N., Pittock, S. J., Weinshenker, B. G., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318214332c · Cited by 296
Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab
Pellkofer, H. L., Krumbholz, M., Berthele, A., Hemmer, B., Gerdes, L. A., Havla, J., Bittner, R., Canis, M., Meinl, E., Hohlfeld, R., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e3182152881 · Cited by 296
Kim, S.-H. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.154 · Cited by 295
Failure of Natalizumab to Prevent Relapses in Neuromyelitis Optica
Kleiter, I. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.216 · Cited by 294
Aquaporin-4 Antibodies in Neuromyelitis Optica and Longitudinally Extensive Transverse Myelitis
Waters, P., Jarius, S., Littleton, E., Leite, M. I., Jacob, S., Gray, B., Geraldes, R., Vale, T., Jacob, A., Palace, J., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.7.913 · Cited by 294
Self-citationEpidemiology of Neuromyelitis Optica in the United States: A Multicenter Analysis
Mealy, M. A., Wingerchuk, D. M., Greenberg, B. M., & Levy, M. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.314 · Cited by 286
Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica
Watanabe, S., Nakashima, I., Misu, T., Miyazawa, I., Shiga, Y., Füjihara, K., & Itoyama, Y. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458506071174 · Cited by 284
Min, J.-H., Kim, B. J., & Lee, K. H. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458511431973 · Cited by 280
The history of neuromyelitis optica
Jarius, S., & Wildemann, B. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-8 · Cited by 279
Self-citationClinical characteristics, course and prognosis of relapsing Devic?s Neuromyelitis Optica
Ghezzi, A., Bergamaschi, R., Martinelli, V., Trojano, M., Tola, M. R., Merelli, E., Mancardi, L., Gallo, P., Filippi, M., Zaffaroni, M., et al. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0271-0 · Cited by 268
Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders
Banwell, B., Tenembaum, S., Lennon, V. A., Ursell, E., Kennedy, J., Bar-Or, A., Weinshenker, B. G., Lucchinetti, C. F., & Pittock, S. J. (2008) · Neurology · doi:10.1212/01.wnl.0000284600.80782.d5 · Cited by 263
Treatment of neuromyelitis optica: review and recommendations
Kimbrough, D. J., Fujihara, K., Jacob, A., Lana-Peixoto, M. A., Isabel Leite, M., Levy, M., Marignier, R., Nakashima, I., Palace, J., de Seze, J., et al. (2012) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2012.06.002 · Cited by 260
Jarius, S., & Wildemann, B. (2013) · Brain Pathology · doi:10.1111/bpa.12084 · Cited by 254
Self-citationAnti–Aquaporin‐4 monoclonal antibody blocker therapy for neuromyelitis optica
Tradtrantip, L., Zhang, H., Saadoun, S., Phuan, P., Lam, C., Papadopoulos, M. C., Bennett, J. L., & Verkman, A. S. (2012) · Annals of Neurology · doi:10.1002/ana.22657 · Cited by 253
Neuromyelitis optica: Passive transfer to rats by human immunoglobulin
Kinoshita, M., Nakatsuji, Y., Kimura, T., Moriya, M., Takata, K., Okuno, T., Kumanogoh, A., Kajiyama, K., Yoshikawa, H., & Sakoda, S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.06.085 · Cited by 249
Azathioprine: Tolerability, efficacy, and predictors of benefit in neuromyelitis optica
Costanzi, C., Matiello, M., Lucchinetti, C. F., Weinshenker, B. G., Pittock, S. J., Mandrekar, J., Thapa, P., & McKeon, A. (2011) · Neurology · doi:10.1212/wnl.0b013e31822a2780 · Cited by 249
Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica
Jiao, Y., Fryer, J. P., Lennon, V. A., Jenkins, S. M., Quek, A. M. L., Smith, C. Y., McKeon, A., Costanzi, C., Iorio, R., Weinshenker, B. G., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a6cb5c · Cited by 244
Vincent, T., Saikali, P., Cayrol, R., Roth, A. D., Bar-Or, A., Prat, A., & Antel, J. P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5730 · Cited by 243
Misu, T., Höftberger, R., Fujihara, K., Wimmer, I., Takai, Y., Nishiyama, S., Nakashima, I., Konno, H., Bradl, M., Garzuly, F., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1116-7 · Cited by 232
Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution
Matthews, L., Marasco, R., Jenkinson, M., Küker, W., Luppe, S., Leite, M. I., Giorgio, A., De Stefano, N., Robertson, N., Johansen-Berg, H., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182887957 · Cited by 225
Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis
Sinnecker, T., Dörr, J., Pfueller, C. F., Harms, L., Ruprecht, K., Jarius, S., Brück, W., Niendorf, T., Wuerfel, J., & Paul, F. (2012) · Neurology · doi:10.1212/wnl.0b013e3182648bc8 · Cited by 214
Self-citationJarius, S., Probst, C., Borowski, K., Franciotta, D., Wildemann, B., Stoecker, W., & Wandinger, K. P. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.01.002 · Cited by 213
Self-citationJarius, S., Franciotta, D., Paul, F., Ruprecht, K., Bergamaschi, R., Rommer, P. S., Reuss, R., Probst, C., Kristoferitsch, W., Wandinger, K. P., et al. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-52 · Cited by 209
Self-citationAntibody to Aquaporin 4 in the Diagnosis of Neuromyelitis Optica
Paul, F., Jarius, S., Aktas, O., Bluthner, M., Bauer, O., Appelhans, H., Franciotta, D., Bergamaschi, R., Littleton, E., Palace, J., et al. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040133 · Cited by 208
Self-citationAyzenberg, I., Kleiter, I., Schröder, A., Hellwig, K., Chan, A., Yamamura, T., & Gold, R. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.1246 · Cited by 206
Immunosuppressive therapy is more effective than interferon in neuromyelitis optica
Papeix, C., Vidal, J.-S., Seze, J. D., Pierrot-Deseilligny, C., Tourbah, A., Stankoff, B., Lebrun, C., Moreau, T., Vermersch, P., Fontaine, B., et al. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458506070732 · Cited by 204
Myasthenia gravis and neuromyelitis optica spectrum disorder: A multicenter study of 16 patients
Leite, M. I., Coutinho, E., Lana-Peixoto, M., Apostolos, S., Waters, P., Sato, D., Melamud, L., Marta, M., Graham, A., Spillane, J., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31825644ff · Cited by 203
Self-citationPosterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders
Magaña, S. M., Matiello, M., Pittock, S. J., McKeon, A., Lennon, V. A., Rabinstein, A. A., Shuster, E., Kantarci, O. H., Lucchinetti, C. F., & Weinshenker, B. G. (2009) · Neurology · doi:10.1212/01.wnl.0000343001.36493.ae · Cited by 202
Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder
Bonnan, M., Valentino, R., Olindo, S., Mehdaoui, H., Smadja, D., & Cabre, P. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458508100837 · Cited by 202
Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis
Naismith, R. T., Tutlam, N. T., Xu, J., Klawiter, E. C., Shepherd, J., Trinkaus, K., Song, S. K., & Cross, A. H. (2009) · Neurology · doi:10.1212/01.wnl.0000345042.53843.d5 · Cited by 201
Beneficial Plasma Exchange Response in Central Nervous System Inflammatory Demyelination
Magaña, S. M. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.34 · Cited by 200
Kim, W., Park, M. S., Lee, S. H., Kim, S.-H., Jung, I. J., Takahashi, T., Misu, T., Fujihara, K., & Kim, H. J. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510376640 · Cited by 194
Does interferon beta treatment exacerbate neuromyelitis optica spectrum disorder?
Kim, S.-H., Kim, W., Li, X. F., Jung, I.-J., & Kim, H. J. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512439439 · Cited by 189
Schneider, E., Zimmermann, H., Oberwahrenbrock, T., Kaufhold, F., Kadas, E. M., Petzold, A., Bilger, F., Borisow, N., Jarius, S., Wildemann, B., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066151 · Cited by 183
Self-citationSaadoun, S., Waters, P., MacDonald, C., Bell, B. A., Vincent, A., Verkman, A. S., & Papadopoulos, M. C. (2012) · Annals of Neurology · doi:10.1002/ana.22686 · Cited by 182
Longitudinal extensive transverse myelitis—it's not all neuromyelitis optica
Trebst, C., Raab, P., Voss, E. V., Rommer, P., Abu-Mugheisib, M., Zettl, U. K., & Stangel, M. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.176 · Cited by 181
NMO-IgG in the diagnosis of neuromyelitis optica
Jarius, S., Franciotta, D., Bergamaschi, R., Wright, H., Littleton, E., Palace, J., Hohlfeld, R., & Vincent, A. (2007) · Neurology · doi:10.1212/01.wnl.0000256822.01222.bd · Cited by 181
Self-citationCognitive impairment and cortical degeneration in neuromyelitis optica
Saji, E., Arakawa, M., Yanagawa, K., Toyoshima, Y., Yokoseki, A., Okamoto, K., Otsuki, M., Akazawa, K., Kakita, A., Takahashi, H., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23721 · Cited by 174
Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic Disease)
Weinstock-Guttman, B., Ramanathan, M., Lincoff, N., Napoli, S. Q., Sharma, J., Feichter, J., & Bakshi, R. (2006) · Archives of Neurology · doi:10.1001/archneur.63.7.957 · Cited by 174
Warabi, Y., Matsumoto, Y., & Hayashi, H. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.10.008 · Cited by 174
Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis
Watanabe, S., Misu, T., Miyazawa, I., Nakashima, I., Shiga, Y., Fujihara, K., & Itoyama, Y. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458507077189 · Cited by 172
Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis
Jarius, S., Frederikson, J., Waters, P., Paul, F., Akman-Demir, G., Marignier, R., Franciotta, D., Ruprecht, K., Kuenz, B., Rommer, P., et al. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.07.011 · Cited by 170
Self-citationAquaporin-4 antibody–negative neuromyelitis optica: Distinct assay sensitivity–dependent entity
Marignier, R., Bernard-Valnet, R., Giraudon, P., Collongues, N., Papeix, C., Zéphir, H., Cavillon, G., Rogemond, V., Casey, R., Frangoulis, B., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e318296e917 · Cited by 170
Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms
Zhang, H., Bennett, J. L., & Verkman, A. S. (2011) · Annals of Neurology · doi:10.1002/ana.22551 · Cited by 168
Walsh, M. J., & Tourtellotte, W. W. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.1.41 · Cited by 168
The differential diagnosis of longitudinally extensive transverse myelitis
Kitley, J., Leite, M., George, J., & Palace, J. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458511406165 · Cited by 165
Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse
Wang, H. H., Dai, Y. Q., Qiu, W., Lu, Z. Q., Peng, F. H., Wang, Y. G., Bao, J., Li, Y., & Hu, X. Q. (2011) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2011.01.031 · Cited by 164
Jarius, S., Jacobi, C., de Seze, J., Zephir, H., Paul, F., Franciotta, D., Rommer, P., Mader, S., Kleiter, I., Reindl, M., et al. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511403958 · Cited by 162
Self-citationIto, S., Mori, M., Makino, T., Hayakawa, S., & Kuwabara, S. (2009) · Annals of Neurology · doi:10.1002/ana.21753 · Cited by 161
Treatment of Optic Neuritis by Plasma Exchange (Add-On) in Neuromyelitis Optica
Merle, H., Olindo, S., Jeannin, S., Valentino, R., Mehdaoui, H., Cabot, F. A., Donnio, A., Hage, R., Richer, R., Smadja, D., et al. (2012) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2012.1126 · Cited by 156
Aquaporin‐4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies
Nicchia, G. P., Mastrototaro, M., Rossi, A., Pisani, F., Tortorella, C., Ruggieri, M., Lia, A., Trojano, M., Frigeri, A., & Svelto, M. (2009) · Glia · doi:10.1002/glia.20855 · Cited by 155
Rostasy, K. M., Mader, S., Hennes, E. M., Schanda, K., Gredler, V., Guenther, A., Blaschek, A., Korenke, C., Pritsch, M., Pohl, D., et al. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512470310 · Cited by 154
Eosinophil pathogenicity mechanisms and therapeutics in neuromyelitis optica.
Zhang, H., & Verkman, A. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67554 · Cited by 151
Patterns of Antibody Binding to Aquaporin-4 Isoforms in Neuromyelitis Optica
Mader, S., Lutterotti, A., Pauli, F. D., Kuenz, B., Schanda, K., Aboul‐Enein, F., Khalil, M., Storch, M. K., Jarius, S., Kristoferitsch, W., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010455 · Cited by 150
Self-citationImpact of rituximab on relapse rate and disability in neuromyelitis optica
Bedi, G. S., Brown, A. D., Delgado, S. R., Usmani, N., Lam, B. L., & Sheremata, W. A. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511404586 · Cited by 148
Phuan, P.-W., Ratelade, J., Rossi, A., Tradtrantip, L., & Verkman, A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.344325 · Cited by 146
Matiello, M., Kim, H. J., Kim, W., Brum, D. G., Barreira, A. A., Kingsbury, D. J., Plant, G. T., Adoni, T., & Weinshenker, B. G. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ea9f15 · Cited by 144
Mayer, M. C., Breithaupt, C., Reindl, M., Schanda, K., Rostasy, K. M., Berger, T., Dale, R. C., Brilot, F., Olsson, T. P., Jenne, D. E., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301296 · Cited by 144
Elsone, L., Panicker, J., Mutch, K., Boggild, M., Appleton, R. E., & Jacob, A. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513495938 · Cited by 144
The clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes
Sellner, J., Hemmer, B., & Mühlau, M. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.09.013 · Cited by 142
In vivo identification of morphologic retinal abnormalities in neuromyelitis optica
Sotirchos, E. S., Saidha, S., Byraiah, G., Mealy, M. A., Ibrahim, M., Sepah, Y. J., Newsome, S. D., Ratchford, J. N., Frohman, E. M., Balcer, L. J., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31828c2f7a · Cited by 141
HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis
Brum, D. G., Barreira, A. A., dos Santos, A. C., Kaimen-Maciel, D. R., Matiello, M., Costa, R. M., Deghaide, N. H. S., Costa, L. S., Louzada‐Júnior, P., Diniz, P. R. B., et al. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458509350741 · Cited by 139
Jarius, S., Paul, F., Franciotta, D. M., Seze, J. D., Münch, C., Salvetti, M., Ruprecht, K., Liebetrau, M., Wandinger, K. P., Akman‐Demir, G., et al. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511431728 · Cited by 137
Self-citationDiagnosis and Treatment of Neuromyelitis Optica
Wingerchuk, D. M. (2007) · The Neurologist · doi:10.1097/01.nrl.0000250927.21903.f8 · Cited by 136
Recurrent Optic Neuromyelitis with Endocrinopathies: A New Syndrome
Vernant, J. C., Cabre, P., Smadja, D., Merle, H., Caubarrère, I., Mikol, J., & Poser, C. M. (1997) · Neurology · doi:10.1212/wnl.48.1.58 · Cited by 134
Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution
Bizzoco, E., Lolli, F., Repice, A., Hakiki, B., Falcini, M., Barilaro, A., Taiuti, R., Siracusa, G., Amato, M., Biagioli, T., et al. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5171-x · Cited by 131
Yonezu, T., Ito, S., Mori, M., Ogawa, Y., Makino, T., Uzawa, A., & Kuwabara, S. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513495581 · Cited by 129
Microcystic Inner Nuclear Layer Abnormalities and Neuromyelitis Optica
Gelfand, J. M., Cree, B., Nolan, R. C., Arnow, S., & Green, A. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.1832 · Cited by 127
Pain in neuromyelitis optica and its effect on quality of life: A cross-sectional study
Kanamori, Y., Nakashima, I., Takai, Y., Nishiyama, S., Kuroda, H., Takahashi, T., Kanaoka, C., Misu, T., Fujihara, K., & Itoyama, Y. (2011) · Neurology · doi:10.1212/wnl.0b013e318229e694 · Cited by 126
Kim, S., Kim, W., Huh, S., Lee, K. Y., Jung, I. J., & Kim, H. J. (2013) · Journal of Clinical Neurology · doi:10.3988/jcn.2013.9.1.36 · Cited by 126
Neuromyelitis optica: Aquaporin-4 based pathogenesis mechanisms and new therapies
Ratelade, J., & Verkman, A. (2012) · International Journal of Biochemistry and Cell Biology · doi:10.1016/j.biocel.2012.06.013 · Cited by 124
Kaufhold, F., Zimmermann, H. G., Schneider, E., Ruprecht, K., Paul, F., Oberwahrenbrock, T., & Brandt, A. U. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071145 · Cited by 124
Self-citationCognitive Functions in Neuromyelitis Optica
Blanc, F., Zéphir, H., Lebrun‐Frénay, C., Labauge, P. M., Castelnovo, G., Fleury, M., Sellal, F., Tranchant, C., Dujardin, K., Vermersch, P., et al. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.16 · Cited by 123
No MRI evidence of cortical lesions in neuromyelitis optica
Calabrese, M., Oh, M. S., Favaretto, A., Rinaldi, F., Poretto, V., Alessio, S., Lee, B., Yu, K., Ma, H., Perini, P., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31826e9a96 · Cited by 122
Zimmermann, H. G., Freing, A., Kaufhold, F., Gaede, G., Bohn, E., Bock, M., Oberwahrenbrock, T., Young, K. L., Dörr, J., Wuerfel, J. T., et al. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512457844 · Cited by 122
Self-citationMassive astrocyte destruction in neuromyelitis optica despite natalizumab therapy
Barnett, M. H., Prineas, J. W., Buckland, M., Parratt, J., & Pollard, J. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511421185 · Cited by 122
Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis
Uzawa, A., Mori, M., Ito, M., Uchida, T., Hayakawa, S., Masuda, S., & Kuwabara, S. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5274-4 · Cited by 121
Influence of pregnancy on neuromyelitis optica spectrum disorder
Kim, W., Kim, S. H., Nakashima, I., Takai, Y., Fujihara, K., Leite, M. I., Kitley, J., Palace, J. A., Santos, E., Coutinho, E., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318250d812 · Cited by 121
Disease Amelioration With Tocilizumab in a Treatment-Resistant Patient With Neuromyelitis Optica
Kieseier, B. C., Stüve, O., Dehmel, T., Goebels, N., Leussink, V. I., Mausberg, A. K., Ringelstein, M., Turowski, B., Aktaş, O., Antoch, G., et al. (2012) · JAMA Neurology · doi:10.1001/jamaneurol.2013.668 · Cited by 118
Is neuromyelitis optica associated with human leukocyte antigen?
Zéphir, H., Fajardy, I., Outteryck, O., Blanc, F., Roger, N., Fleury, M., Rudolf, G., Marignier, R., Vukusic, S., Confavreux, C., et al. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458508102085 · Cited by 118
White Matter Atrophy and Cognitive Dysfunctions in Neuromyelitis Optica
Blanc, F., Noblet, V., Jung, B., Rousseau, F., Renard, F., Bourre, B., Longato, N., Cremel, N., Bitonto, L. D., Kleitz, C., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033878 · Cited by 117
Hinson, S. R., McKeon, A. B., Fryer, J. P., Apiwattanakul, M., Lennon, V. A., & Pittock, S. J. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.188 · Cited by 117
Absence of cortical demyelination in neuromyelitis optica
Popescu, B. F. G., Parisi, J. E., Cabrera-Gómez, J. A., Newell, K. L., Mandler, R. N., Pittock, S. J., Lennon, V. A., Weinshenker, B. G., & Lucchinetti, C. F. (2010) · Neurology · doi:10.1212/wnl.0b013e318200d80c · Cited by 115
Neuromyelitis optica: Effect of gender
Wingerchuk, D. M. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.08.045 · Cited by 114
Greenberg, B. M., Graves, D. F., Remington, G. M., Hardeman, P., Mann, M., Karandikar, N. J., Stüve, O., Monson, N. L., & Frohman, E. M. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458511432896 · Cited by 114
Brain Involvement in Neuromyelitis Optica Spectrum Disorders
Chan, K. H., Tse, C. T., Chung, C. P., Lee, R. L. C., Kwan, J. S. C., Ho, P. W. L., & Ho, J. W. M. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.249 · Cited by 112
Incidence of acquired demyelinating syndromes of the CNS in Dutch children: a nationwide study
Ketelslegers, I. A., Catsman‐Berrevoets, C. E., Neuteboom, R. F., Boon, M., van Dijk, K. G. J., Eikelenboom, M. J., Gooskens, R. H. J. M., Niks, E. H., Overweg‐Plandsoen, W. C. G., Peeters, E. A. J., et al. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6441-6 · Cited by 112
Enhanced IL-6 Production in Aquaporin-4 Antibody Positive Neuromyelitis Optica Patients
İçöz, S., Tüzün, E., Kürtüncü, M., Durmuş, H., Mutlu, M., Eraksoy, M., & Akman‐Demir, G. (2010) · International Journal of Neuroscience · doi:10.3109/00207450903428970 · Cited by 111
Brain abnormalities as an initial manifestation of neuromyelitis optica spectrum disorder
Kim, W., Kim, S., Lee, S. H., Li, X. F., & Kim, H. J. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511404917 · Cited by 110
Neuromyelitis Optica Treatment: Analysis of 36 Patients
Bichuetti, D. B., de Oliveira, E. M. L., Oliveira, D. M., de Souza, N. A., & Gabbai, A. A. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.203 · Cited by 107
Brain Abnormalities in Neuromyelitis Optica Spectrum Disorder
Kim, W., Kim, S., Huh, S., & Kim, H. J. (2012) · Multiple Sclerosis International · doi:10.1155/2012/735486 · Cited by 106
Association of Neuromyelitis Optica With Severe and Intractable Pain
Qian, P., Lancia, S., Álvarez, E., Klawiter, E. C., Cross, A. H., & Naismith, R. T. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.768 · Cited by 106
Neuromyelitis Optica IgG Causes Placental Inflammation and Fetal Death
Saadoun, S., Waters, P. J., Leite, M. I., Bennett, J. L., Vincent, A. C., & Papadopoulos, M. C. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301483 · Cited by 106
Cree, B., Goodin, D. S., & Hauser, S. L. (2002) · Seminars in Neurology · doi:10.1055/s-2002-36534 · Cited by 106
Araki, M., Aranami, T., Matsuoka, T., Nakamura, M., Miyake, S., & Yamamura, T. (2012) · Modern Rheumatology · doi:10.1007/s10165-012-0715-9 · Cited by 105
The prevalence of neuromyelitis optica in South East Wales
Cossburn, M., Tackley, G., Baker, K., Ingram, G., Burtonwood, M. T., Malik, G., Pickersgill, T. P., Naudé, J. T. W., & Robertson, N. P. (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03529.x · Cited by 101
Uzawa, A., Mori, M., Hayakawa, S., Masuda, S., & Kuwabara, S. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02897.x · Cited by 100
NMDA RECEPTOR ENCEPHALITIS MIMICKING SERONEGATIVE NEUROMYELITIS OPTICA
Kruer, M. C., Koch, T., BOURDETTE, D. N., Chabas, D., Waubant, E. L., Mueller, S. G., Moscarello, M. A., Dalmau, J. O., Woltjer, R. L., & Adamus, G. (2010) · Neurology · doi:10.1212/wnl.0b013e3181dc1a7f · Cited by 98
Efficacy and Safety of Mitoxantrone in Patients With Highly Relapsing Neuromyelitis Optica
Kim, S., Kim, W., Park, M. S., Sohn, E. H., Li, X. F., & Kim, H. J. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.322 · Cited by 98
Differential diagnosis of longitudinally extensive transverse myelitis
Apóstolos‐Pereira, S. L., Marchiori, P. E., Dellavance, A., Jorge, F., Gomes, H. R., Lucato, L. T., Simm, R., Sato, D. K., & Callegaro, D. (2013) · Arquivos de Neuro-Psiquiatria · Cited by 98
Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss
Ratelade, J., Zhang, H., Saadoun, S., Bennett, J., Papadopoulos, M., & Verkman, A. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0986-4 · Cited by 97
The epidemiology of neuromyelitis optica amongst adults in the Merseyside county of United Kingdom
Jacob, A., Panicker, J., Lythgoe, D. T., Elsone, L., Mutch, K., Wilson, M., Das, K., & Boggild, M. (2013) · Journal of Neurology · doi:10.1007/s00415-013-6926-y · Cited by 97
Activation of Kainate Receptors Sensitizes Oligodendrocytes to Complement Attack
Alberdi, E. M., Sánchez‐Gómez, M. V., Torre, I., Domercq, M., Pérez‐Samartín, A., Pérez‐Cerdá, F., & Matute, C. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3780-05.2006 · Cited by 96
Araki, M., Aranami, T., Matsuoka, T., Nakamura, M., Miyake, S., & Yamamura, T. (2013) · Modern Rheumatology · doi:10.3109/s10165-012-0715-9 · Cited by 96
Cytotoxic effect of neuromyelitis optica antibody (NMO-IgG) to astrocytes: An in vitro study
Sabater, L., Giralt, A., Boronat, A., Hankiewicz, K., Blanco, Y., Llufriú, S., Alberch, J., Graus, F., & Saiz, A. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.07.014 · Cited by 94
Kinoshita, M., Nakatsuji, Y., Kimura, T., Moriya, M., Takata, K., Okuno, T., Kumanogoh, A., Kajiyama, K., Yoshikawa, H., & Sakoda, S. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.157 · Cited by 94
Diagnosis of Neuromyelitis Spectrum Disorders
McKeon, A. B., Fryer, J. P., Apiwattanakul, M., Lennon, V. A., Hinson, S. R., Kryzer, T. J., Lucchinetti, C. F., Weinshenker, B. G., Wingerchuk, D. M., Shuster, E. A., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.178 · Cited by 94
Wang, H., Wang, K., Zhong, X., Qiu, W., Dai, Y., Wu, A., & Hu, X. (2012) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9709-9 · Cited by 93
Wandinger, K., Stangel, M., Witte, T., Venables, P. J., Charles, P. J., Jarius, S., Wildemann, B., Probst, C., Iking‐Konert, C., & Schneider, M. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27337 · Cited by 93
Self-citationKitley, J., Elsone, L., George, J., Waters, P. J., Woodhall, M. R., Vincent, A. C., Jacob, A., Leite, M. I., & Palace, J. A. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304774 · Cited by 93
Kalluri, S. R., Illés, Z., Srivastava, R., Cree, B., Menge, T., Bennett, J. L., Berthele, A., & Hemmer, B. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.269 · Cited by 92
Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica
Jarius, S., Franciotta, D. M., Bergamaschi, R., Rauer, S., Wandinger, K.-P., Petereit, H.-F., Mäurer, M., Tumani, H., Vincent, A. C., Eichhorn, P., et al. (2008) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.133330 · Cited by 91
Self-citationOptic Nerve Head Quantification in Idiopathic Intracranial Hypertension by Spectral Domain OCT
Kaufhold, F., Kadas, E. M., Schmidt, C. G., Kunte, H., Hoffmann, J., Zimmermann, H. G., Oberwahrenbrock, T., Harms, L., Polthier, K., Brandt, A. U., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036965 · Cited by 90
Self-citationTradtrantip, L., Ratelade, J., Zhang, H., & Verkman, A. S. (2012) · Annals of Neurology · doi:10.1002/ana.23741 · Cited by 89
Sinclair, C., Kirk, J., Herron, B. M., FitzGerald, U., & McQuaid, S. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0169-2 · Cited by 88
Does natalizumab therapy worsen neuromyelitis optica?
Jacob, A., Hutchinson, M., Elsone, L., Kelly, S. B., Ali, R., Saukans, I., Tubridy, N. J., & Boggild, M. (2012) · Neurology · doi:10.1212/wnl.0b013e31826845fe · Cited by 87
Tradtrantip, L., Zhang, H., Anderson, M. O., Saadoun, S., Phuan, P., Papadopoulos, M. C., Bennett, J. L., & Verkman, A. S. (2012) · The FASEB Journal · doi:10.1096/fj.11-201608 · Cited by 84
Aquaporin 4 Expression and Tissue Susceptibility to Neuromyelitis Optica
Matiello, M., Schaefer-Klein, J. L., Sun, D. A., & Weinshenker, B. G. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.3124 · Cited by 83
Kim, W., Lee, J. E., Li, X. F., Kim, S., Han, B.-G., Lee, B. I., Kim, J. K., Choi, K., & Kim, H. J. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511424590 · Cited by 83
Jarius, S., Eichhorn, P., Jacobi, C., Wildemann, B., Wick, M. W., & Voltz, R. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.08.002 · Cited by 83
Self-citationNeuromyelitis optica and pregnancy
Fragoso, Y. D., Adoni, T., Bichuetti, D. B., Brooks, J. B. B., Ferreira, M. L. B., de Oliveira, E. M. L., Oliveira, C. L. S., Ribeiro, S. B. M. H. A., Silva, A. E., & Siquineli, F. (2013) · Journal of Neurology · doi:10.1007/s00415-013-7031-y · Cited by 81
A serological analysis of viral and bacterial infections associated with neuromyelitis optica
Koga, M., Takahashi, T., Kawai, M., Fujihara, K., & Kanda, T. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.10.013 · Cited by 80
Linhares, U. C., Schiavoni, P. B., Barros, P. O., Kasahara, T. M., Teixeira, B., Ferreira, T. B., Alvarenga, R., Hygino, J., Vieira, M. M. M., Bittencourt, V. C. B., et al. (2013) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9780-2 · Cited by 78
Quan, C., Yu, H., Qiao, J., Xiao, B., Zhao, G., Wu, Z., Li, Z., & Lü, C. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512454771 · Cited by 78
Spinal cord tract diffusion tensor imaging reveals disability substrate in demyelinating disease
Naismith, R. T., Xu, J., Klawiter, E. C., Lancia, S., Tutlam, N. T., Wagner, J. M., Qian, P., Trinkaus, K. M., Song, S., & Cross, A. H. (2013) · Neurology · doi:10.1212/wnl.0b013e318296e8f1 · Cited by 77
Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients
Akman‐Demir, G., Tüzün, E., Waters, P. J., İçöz, S., Kürtüncü, M., Jarius, S., Yapıcı, Z., Mutlu, M., Yeşilot, N., Vincent, A. C., et al. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5780-4 · Cited by 76
Self-citationReiber, H., Teut, M., Pohl, D., Rostasy, K. M., & Hanefeld, F. A. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458509348418 · Cited by 76
Ultrahigh-Field MR (7 T) Imaging of Brain Lesions in Neuromyelitis Optica
Kister, I., Herbert, J., Zhou, Y., & Ge, Y. (2013) · Multiple Sclerosis International · doi:10.1155/2013/398259 · Cited by 75
Jarius, S., Franciotta, D. M., Paul, F., Bergamaschi, R., Rommer, P. S., Ruprecht, K., Ringelstein, M., Aktaş, O., Kristoferitsch, W., & Wildemann, B. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.06.002 · Cited by 75
Self-citationNeuromyelitis optica preceded by hyperCKemia episode
Suzuki, N., Takahashi, T., Aoki, M., Misu, T., Konohana, S., Okumura, T., Takahashi, H., Kameya, S., Yamaki, K., Kumagai, T., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181dd445b · Cited by 71
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone
Martinelli, V., Cocco, E. E., Capra, R., Salemi, G., Gallo, P., Capobianco, M. A. N., Pesci, I., Ghezzi, A., Pozzilli, C., Lugaresi, A., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318238ee00 · Cited by 71
von Glehn, F., Jarius, S., Lira, R. P. C., Ferreira, M. C. A., Ribeiro, F. H., Castro, S. M. C. E., Beltramini, G. C., Bergo, F. P. G., Farias, A. S., Brandão, C. O., et al. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458513519838 · Cited by 70
Self-citationRatelade, J., Bennett, J. L., & Verkman, A. S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.297275 · Cited by 69
ACUTE DISSEMINATED ENCEPHALOMYELITIS FOLLOWING VACCINATION AGAINST HUMAN PAPILLOMA VIRUS
Bomprezzi, R. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d2b508 · Cited by 69
Kuroda, H., Fujihara, K., Takano, R., Takai, Y., Takahashi, T., Misu, T., Nakashima, I., Sato, S., Itoyama, Y., & Aoki, M. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.09.002 · Cited by 69
Tradtrantip, L., Asavapanumas, N., & Verkman, A. S. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.086470 · Cited by 69
Jarius, S., Wandinger, K., Borowski, K., Stoecker, W., & Wildemann, B. (2012) · Clinical neurology and neurosurgery (Dutch-Flemish ed. Print) · doi:10.1016/j.clineuro.2011.10.048 · Cited by 68
Self-citationPrimary retinal pathology in multiple sclerosis as detected by optical coherence tomography
Brandt, A. U., Oberwahrenbrock, T., Ringelstein, M., Young, K. L., Tiede, M., Hartung, H. ‐., Martinꝉ, R., Aktaş, O., Paul, F., & Schippling, S. (2011) · Brain · doi:10.1093/brain/awr095 · Cited by 68
Self-citationBöck, M., Brandt, A. U., Dörr, J., Pfueller, C. F., Ohlraun, S., Zipp, F., & Paul, F. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510365156 · Cited by 68
Self-citationLiu, Y., Duan, Y., Yong He, A., Yu, C., Wang, J., Huang, J., Ye, J., Butzkueven, H., Li, K., & Shu, N. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511431731 · Cited by 68
Temporal Retinal Nerve Fiber Loss in Patients with Spinocerebellar Ataxia Type 1
Stricker, S., Oberwahrenbrock, T., Zimmermann, H. G., Schroeter, J., Endres, M., Brandt, A. U., & Paul, F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023024 · Cited by 66
Self-citationKalluri, S., Rothhammer, V., Staszewski, O., Srivastava, R., Petermann, F., Prinz, M., Hemmer, B., & Korn, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016083 · Cited by 65
Patterns of Retinal Damage Facilitate Differential Diagnosis between Susac Syndrome and MS
Brandt, A. U., Zimmermann, H. G., Kaufhold, F., Promesberger, J., Schippling, S., Finis, D., Aktaş, O., Geis, C., Ringelstein, M., Ringelstein, E. B., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038741 · Cited by 65
Self-citationEfficacy of mitoxantrone in neuromyelitis optica spectrum: clinical and neuroradiological study
Cabre, P., Olindo, S., Marignier, R., Jeannin, S., Merle, H., Smadja, D., & Sclerosis, U. T. A. O. T. F. N. O. O. M. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303121 · Cited by 64
Visual evoked potentials in neuromyelitis optica and its spectrum disorders
Ringelstein, M., Kleiter, I., Ayzenberg, I., Borisow, N., Paul, F., Ruprecht, K., Kraemer, M., Cohn, E., Wildemann, B., Jarius, S., et al. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513503053 · Cited by 64
Self-citationACUTE DISSEMINATED ENCEPHALOMYELITIS FOLLOWING VACCINATION AGAINST HUMAN PAPILLOMA VIRUS
Wildemann, B., Jarius, S., Hartmann, M., Regula, J. U., & Hametner, C. (2009) · Neurology · doi:10.1212/wnl.0b013e3181aa53bb · Cited by 63
Self-citationNeuromyelitis optica and NMO-IgG in European pediatric patients
Huppke, P., Blüthner, M., Bauer, O., Stark, W., Reinhardt, K., Huppke, B., & Gärtner, J. (2010) · Neurology · doi:10.1212/wnl.0b013e3181fc2823 · Cited by 61
The Role of Demyelination in Neuromyelitis Optica Damage: Diffusion-Tensor MR Imaging Study
Lopes, F. C. R., Doring, T. M., Martins, C., Cabral, F. C., Malfetano, F. R., Pereira, V. C. S. R., Alves‐Leon, S. V., & Gasparetto, E. L. (2012) · Radiology · doi:10.1148/radiol.12111241 · Cited by 61
Roth, N. M., Saidha, S., Zimmermann, H. G., Brandt, A. U., Oberwahrenbrock, T., Maragakis, N. J., Tumani, H., Ludolph, A. C., Meyer, T., Calabresi, P. A., et al. (2013) · European Journal of Neurology · doi:10.1111/ene.12146 · Cited by 58
Self-citationCourse of neuromyelitis optica during inadvertent pregnancy in a patient treated with rituximab
Pellkofer, H., Süßmair, C., Schulze, A., Hohlfeld, R., & Kümpfel, T. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458509106512 · Cited by 58
Cited by
in cooperation with the Neuromyelitis Optica Study Group (NEMOS), Jarius, S., Ruprecht, K., Kleiter, I., Borisow, N., Asgari, N., Pitarokoili, K., Pache, F., Stich, O., Beume, L.-A., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0718-0 · Cited by 899
Self-citationTraboulsee, A., Greenberg, B. M., Bennett, J. L., Szczechowski, L., Fox, E., Shkrobot, S., Yamamura, T., Terada, Y., Kawata, Y., Wright, P., et al. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30078-8 · Cited by 513
Jarius, S., Paul, F., Weinshenker, B. G., Levy, M., Kim, H. J., & Wildemann, B. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0214-9 · Cited by 478
Self-citationNeuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses
Kleiter, I., Gahlen, A., Borisow, N., Fischer, K., Wernecke, K., Wegner, B., Hellwig, K., Pache, F., Ruprecht, K., Havla, J., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24554 · Cited by 432
Self-citationin cooperation with the Neuromyelitis Optica Study Group (NEMOS), Jarius, S., Ruprecht, K., Kleiter, I., Borisow, N., Asgari, N., Pitarokoili, K., Pache, F., Stich, O., Beume, L.-A., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0717-1 · Cited by 429
Self-citation
Metadata
- Authors
- Jarius, S., Wildemann, B., & Paul, F.
- Venue
- Clinical and Experimental Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-04-09
- Volume
- 176
- Issue
- 2
- Pages
- 149-164
- ISSN
- 0009-9104 (ISSN-L)
- 1365-2249
- OpenAlex
- W1598350516
- Cited by
- 342
- References
- 270
- FWCI
- 21.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.